IVERIC bio (OPHT) News Today → A lot of people are making this costly mistake (From WealthPress) (Ad) Free OPHT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGossamer Bio Inc GOSSmorningstar.com - November 5 at 6:12 PMIveric Bio ticks higher as it sees sale to Astellas closing July 11msn.com - June 30 at 12:31 AMIveric Bio falls amid concern about Astellas dealmsn.com - June 29 at 9:29 AMBaird Downgrades IVERIC bio (ISEE)msn.com - May 6 at 8:26 PMApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric Biomsn.com - May 6 at 8:26 PMIveric Bio (NASDAQ:ISEE) Sold for $5.9Bmsn.com - May 2 at 12:39 AMAstellas to Buy Eye-Drug Maker Iveric Bio for $5.9 Billionmsn.com - May 1 at 2:38 PMAstellas Pharma buys Iveric Bio for $5.9 billionreuters.com - May 1 at 4:38 AMAstellas Pharma to Buy Iveric Bio for $5.9 Billionmsn.com - April 30 at 10:14 PMAstellas Pharma to Buy Iveric Bio for About $5.9Bwsj.com - April 30 at 10:14 PMAstellas Pharma agrees to buy Iveric Bio for $5.9 Billionmsn.com - April 30 at 10:14 PMRobert W. Baird Keeps Their Buy Rating on Iovance Biotherapeutics (IOVA)markets.businessinsider.com - March 3 at 1:42 AMIVERIC Bio Shares Up 14% After Positive Trial Results, 4Q Lossesmarketwatch.com - March 1 at 11:24 AMIveric Bio Shares Rise 16% After FDA Accepts New Drug App for Avacincaptad Pegolmarketwatch.com - February 17 at 8:38 PMDeep Track Capital Now Owns 5.88% of IVERIC bio (ISEE)nasdaq.com - February 16 at 3:27 PMRtw Investments Now Owns 0.60% of IVERIC bio (ISEE)nasdaq.com - February 16 at 3:27 PMISEE IVERIC bio, Inc.seekingalpha.com - September 16 at 8:03 AMWhere IVERIC bio Stands With Analystsmarkets.businessinsider.com - September 7 at 1:06 PMIveric Bio To Announce GATHER2 Trial Data In Septembermarkets.businessinsider.com - August 25 at 5:15 AMWhy Ophthotech (OPHT) Stock Is Surging Todaythestreet.com - January 18 at 6:26 PMIVERIC bio, Inc. 2021 Q2 - Results - Earnings Call Presentationseekingalpha.com - August 9 at 5:37 AM Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent: Protect Your Investments from a Chinese Invasion (Ad)An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion. Click here to get my exclusive report NOW >>> OPHT Media Mentions By Week OPHT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHT News Sentiment▼0.000.60▲Average Medical News Sentiment OPHT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHT Articles This Week▼00▲OPHT Articles Average Week Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGIO News Today PTGX News Today MORF News Today DVAX News Today EWTX News Today TARO News Today ARDX News Today ZLAB News Today KURA News Today SUPN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPHT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IVERIC bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.